IMA vs VRTX: Which Stock is Better?
Side-by-side comparison of Imagenebio Inc and Vertex Pharmaceuticals Inc in 2026
IMA
Imagenebio Inc
$4.90
VRTX
Vertex Pharmaceuticals Inc
$444.28
Key Metrics Comparison
| Metric | IMA | VRTX | Winner |
|---|---|---|---|
| Market Cap | $54.83M | $111.93B | VRTX |
| P/E Ratio | N/A | 28.74 | VRTX |
| EPS (TTM) | $N/A | $15.31 | VRTX |
| Revenue Growth | 0.0% | 0.1% | VRTX |
| Gross Margin | 100.0% | 53.7% | IMA |
Analyze IMA
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IMA or VRTX a better investment?
Comparing IMA and VRTX: Imagenebio Inc has a market cap of $54.83M while Vertex Pharmaceuticals Inc has $111.93B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IMA and VRTX?
IMA (Imagenebio Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IMA or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IMA or VRTX?
VRTX has higher revenue growth at 0.1% vs 0.0% for IMA.
Which company is more profitable: IMA or VRTX?
Imagenebio Inc (IMA) has higher gross margins at 100.0% compared to 53.7% for VRTX.
Which is the larger company: IMA or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $111.93B compared to $54.83M for IMA.
Should I buy IMA or VRTX in 2026?
Both IMA and VRTX have investment merit. IMA trades at $4.90 while VRTX trades at $444.28. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IMA and VRTX stock?
Key differences: Market Cap ($54.83M vs $111.93B), P/E Ratio (N/A vs 28.7x), Revenue Growth (0.0% vs 0.1%), Gross Margin (100.0% vs 53.7%).